Sangamo Therapeutics

(OTC) SGMO

Current Price$0.20

Market Cap$82.86M

Since IPO (2000)-99%

5 Year-98%

1 Year-56%

1 Month-5%

Sangamo Therapeutics Financials at a Glance

Market Cap

$82.86M

Revenue (TTM)

$34.56M

Net Income (TTM)

-$123.33M

EPS (TTM)

-$0.38

P/E Ratio

-0.52

Dividend

$0.00

Beta (Volatility)

1.62 (High)

Dividend

$0.00

Beta (Volatility)

1.62 (High)

Price

$0.20

Volume

2,321,925

Open

$0.19

Price

$0.20

Volume

2,321,925

Open

$0.19

Previous Close

$0.20

Daily Range

$0.17 - $0.21

52-Week Range

$0.10 - $0.77

Dividend

$0.00

Beta (Volatility)

1.62 (High)

Price

$0.20

Volume

2,321,925

Open

$0.19

Previous Close

$0.20

Daily Range

$0.17 - $0.21

52-Week Range

$0.10 - $0.77

SGMO News

Pfizer and Sangamo's Gene Therapy Continues to Help Patients with Hemophilia in Clinical Trial

Brian Orelli, PhDJun 18, 2020

Better Buy: CRISPR Therapeutics vs. Sangamo Therapeutics

Alex CarchidiJun 14, 2020

Better Buy: Cara Therapeutics vs. Sangamo Therapeutics

Keith SpeightsApr 29, 2020

Better Buy: Editas Medicine vs Sangamo Therapeutics

Mark PrvulovicApr 1, 2020

3 Top Stocks You've Probably Never Heard Of

Mark PrvulovicMar 28, 2020

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sangamo Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

142

CEO

Alexander D. Macrae, PhD

Website

www.sangamo.com

Headquarters

Richmond, CA 94005, US

SGMO Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-3%

Net Income Margin

-4%

Return on Equity

-2892%

Return on Capital

-16%

Return on Assets

-2%

Earnings Yield

-1.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$82.86M

Shares Outstanding

414.29M

Volume

2.32M

Avg. Volume

10.10M

Financials (TTM)

Gross Profit

$31.95M

Operating Income

-$108.00M

EBITDA

-$100.40M

Operating Cash Flow

-$97.21M

Capital Expenditure

-$102.00K

Free Cash Flow

-$97.31M

Cash & ST Invst.

$20.95M

Total Debt

$26.80M

Sangamo Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$1.44M

-77.6%

Gross Profit

$1.44M

-77.6%

Gross Margin

100.00%

N/A

Market Cap

$82.86M

N/A

Market Cap/Employee

$452.77K

N/A

Employees

183

N/A

Net Income

-$31.00M

-1.3%

EBITDA

-$31.07M

-12.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$8.25M

+2615.1%

Accounts Receivable

$873.00K

-81.1%

Inventory

$0.00

N/A

Long Term Debt

$19.33M

-22.3%

Short Term Debt

$0.00

N/A

Return on Assets

-2.06%

N/A

Return on Invested Capital

-16.15%

N/A

Free Cash Flow

-$19.30M

+26.2%

Operating Cash Flow

-$19.28M

+26.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RANIRani Therapeutics Holdings, Inc.

RANIRani Therapeutics Holdings, Inc.$0.95+1.01%

MISTMilestone Pharmaceuticals Inc.

MISTMilestone Pharmaceuticals Inc.$1.40+0.00%

IVVDInvivyd, Inc.

IVVDInvivyd, Inc.$1.13+2.73%

MOLNMolecular Partners AG

MOLNMolecular Partners AG$4.04-0.25%

IPHAInnate Pharma S.A.

IPHAInnate Pharma S.A.$1.75+1.74%

IMDXInsight Molecular Diagnostics Inc.

IMDXInsight Molecular Diagnostics Inc.$6.41-0.47%

CDXSCodexis, Inc.

CDXSCodexis, Inc.$2.64+1.54%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ASTCAstrotech

ASTCAstrotech$13.81+4.59%

ONDSOndas

ONDSOndas$10.80+0.11%

FFord Motor Company

FFord Motor Company$15.88+0.04%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.92+0.01%

TET1 Energy Inc.

TET1 Energy Inc.$10.96+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.28+0.03%

SOFISoFi Technologies

SOFISoFi Technologies$16.17+0.01%

Questions About SGMO

What is the current price of Sangamo Therapeutics?

Sangamo Therapeutics is trading at $0.20 per share.

What is the 52-week range for Sangamo Therapeutics?

Over the past 52 weeks, Sangamo Therapeutics has traded between $0.10 and $0.77.

How much debt does Sangamo Therapeutics have?

As of the most recent reporting period, Sangamo Therapeutics reported total debt of $19.33M.

How much cash does Sangamo Therapeutics have on hand?

Sangamo Therapeutics reported $27.59M in cash and cash equivalents in its most recent financial results.

What is Sangamo Therapeutics’s dividend yield?

Sangamo Therapeutics does not currently have a dividend yield.

Sangamo Therapeutics

Sangamo Therapeutics Financials at a Glance

SGMO News

Best Gene Editing Stocks for 2026 and How to Invest

CRISPR 101: What Investors Need to Know

3 Top Biotech Stocks to Watch in July

Pfizer and Sangamo's Gene Therapy Continues to Help Patients with Hemophilia in Clinical Trial

Better Buy: CRISPR Therapeutics vs. Sangamo Therapeutics

Better Buy: Cara Therapeutics vs. Sangamo Therapeutics

Better Buy: Editas Medicine vs Sangamo Therapeutics

3 Top Stocks You've Probably Never Heard Of

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sangamo Therapeutics

SGMO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sangamo Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SGMO

What is the current price of Sangamo Therapeutics?

What is the 52-week range for Sangamo Therapeutics?

How much debt does Sangamo Therapeutics have?

How much cash does Sangamo Therapeutics have on hand?

What is Sangamo Therapeutics’s dividend yield?

Premium Investing Services